LONSERA
Live / Registered — Registered — Section 8 accepted (as of 24 Jul 2023)
What this means for you
Registered since 27 Jun 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 27 Jun 2027, and its filing window is open now).
Record
- Serial number
- 87009285
- Registration number
- 5233702
- Mark type
- Design + words
- Filed
- 21 Apr 2016
- Published for opposition
- 08 Nov 2016
- Registered
- 27 Jun 2017
- Next maintenance filing
- §8 & §9 renewal, due by 27 Jun 2027 (grace period to 27 Dec 2027)
Goods and services
- Class 001 — Chemicals: Fetal bovine serum for research use
Owner
- Empriza Biotech Inc., Richmond, VA, US
- Empriza Biotech Inc., Richmond, VA, US
- Empriza Biotech Inc., Richmond, VA, US
Prosecution history
- 27 Jun 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 24 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 24 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Feb 2023 — TEAS SECTION 8 RECEIVED
- 27 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 26 May 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 May 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Apr 2017 — USE AMENDMENT FILED
- 04 May 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Apr 2017 — TEAS STATEMENT OF USE RECEIVED
- 03 Jan 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Nov 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED